Anti-Panitumumab Neutralizing Antibody ELISA kit

Catalog No.

KAB86951

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative

Range

15.625-1,000 ng/ml

Precision

CV<20%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Alternative Names

ABX-EGF,E7.6.3, CAS: 339177-26-3

Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumors., PMID:22510349

Immunogenicity of panitumumab in combination chemotherapy clinical trials., PMID:22070868

Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy., PMID:20508254

Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors., PMID:19705240

The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases., PMID:19412429

Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab., PMID:17513798

Document Download

Anti-Panitumumab Neutralizing Antibody ELISA kit.pdf